|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17659810 |
|
NCBI chr18:26,138,382...26,196,021
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21642991 PMID:21874000 PMID:26119930 PMID:26719535 |
|
NCBI chr16:6,453,126...6,461,952
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
|
ISO |
ClinVar Annotator: match by term: Mesothelioma |
ClinVar |
PMID:9989495 PMID:10380920 PMID:10408400 |
|
NCBI chr 2:237,501,181...237,510,821
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
ameliorates |
ISO |
mRNA:increased expression:mesothelium (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:13,285,702...13,313,329
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
exacerbates |
ISO |
mRNA:increased expression:mesothelium (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,567,369...103,580,069
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11283936 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr19:51,402,178...51,471,572
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18301454 |
|
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO IAGP |
CTD Direct Evidence: marker/mechanism DNA:deletion |
CTD RGD |
PMID:18379362 PMID:20065947 |
RGD:7248760 |
NCBI chr 5:109,100,763...109,114,448
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
|
IAGP |
DNA:deletion |
RGD |
PMID:20065947 |
RGD:7248760 |
NCBI chr 5:109,123,308...109,134,906
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11425850 |
|
NCBI chr 6:115,396,308...115,410,594
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21787763 |
|
NCBI chr14:95,378,626...95,551,358
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15878867 |
|
NCBI chr18:26,737,078...26,740,877
|
|
G |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15920167 |
|
NCBI chr 3:112,922,961...112,924,680
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
|
RGD |
PMID:16697254 |
RGD:4889125 |
NCBI chr13:95,246,079...95,275,852
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15639718 PMID:17659810 PMID:17659810 |
RGD:4892302 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15878867 |
|
NCBI chr18:30,937,670...31,023,786
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15878867 |
|
NCBI chr 2:122,164,454...122,218,796
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14569398 PMID:18038314 |
|
NCBI chr15:16,365,401...17,872,901
|
|
G |
Gdf10 |
growth differentiation factor 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18949431 |
|
NCBI chr16:9,237,182...9,250,537
|
|
G |
Gpc3 |
glypican 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10656689 |
|
NCBI chr X:136,789,770...137,157,598
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15920167 |
|
NCBI chr 3:38,982,605...39,035,849
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17290392 |
|
NCBI chr 2:198,338,005...198,346,007
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12768194 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Itln1 |
intelectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15777968 |
|
NCBI chr13:83,932,234...83,958,243
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30619488 |
|
NCBI chr10:102,041,131...102,047,182
|
|
G |
Msln |
mesothelin |
|
ISO IEP |
protein:increased secretion:body fluid CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11751476 PMID:18394747 PMID:20933535 PMID:17785569 PMID:18505465 |
RGD:2326062, RGD:2326046 |
NCBI chr10:14,771,946...14,781,382
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21358348 |
|
NCBI chr 5:164,167,985...164,277,438
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18454162 |
|
NCBI chr 2:176,933,312...176,938,497
|
|
G |
Myo18b |
myosin XVIIIb |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17294804 |
|
NCBI chr12:49,421,062...49,614,127
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12136076 PMID:12168054 PMID:12802287 PMID:16166281 PMID:16319530 PMID:18835652 More...
|
|
NCBI chr14:79,627,399...79,710,709
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15920167 |
|
NCBI chr10:79,394,999...79,400,418
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11415934 |
|
NCBI chr12:15,645,549...15,667,056
|
|
G |
Pdgfc |
platelet derived growth factor C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15920167 |
|
NCBI chr 2:168,613,409...168,791,575
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr 8:14,354,398...14,413,271
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18835652 |
|
NCBI chr 1:84,583,127...84,590,743
|
|
G |
Puf60 |
poly-U binding splicing factor 60 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21435101 |
|
NCBI chr 7:109,663,490...109,674,443
|
|
G |
Rassf1 |
Ras association domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12082623 PMID:15639718 |
|
NCBI chr 8:117,103,665...117,114,805
|
|
G |
Slc6a20a |
solute carrier family 6 member 20a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17659810 |
|
NCBI chr 8:132,159,768...132,200,016
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9533946 PMID:11283936 PMID:15039138 PMID:17290392 |
|
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16221779 PMID:18550471 |
|
NCBI chr14:5,613,569...5,620,695
|
|
G |
Syk |
spleen associated tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17659810 |
|
NCBI chr17:12,756,493...12,830,927
|
|
G |
Tnc |
tenascin C |
disease_progression |
ISO |
|
RGD |
PMID:12605648 PMID:16928692 |
RGD:4889571, RGD:4889612 |
NCBI chr 5:82,391,340...82,476,197
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12151629 |
|
NCBI chr10:54,798,871...54,810,300
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17316382 |
|
NCBI chr 7:22,717,620...22,802,553
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Mesothelioma |
ClinVar |
PMID:4332312 PMID:8298644 |
|
NCBI chr 3:112,019,721...112,068,454
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
ameliorates |
ISO |
mRNA:increased expression:mesothelium (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr X:125,756,107...125,803,979
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16564556 PMID:20705543 |
|
NCBI chr 1:89,268,721...89,296,619
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16564556 |
|
NCBI chr 6:136,684,558...136,694,822
|
|
|
G |
Traf7 |
TNF receptor associated factor 7 |
|
ISO |
DNA:missense mutations:multiple |
RGD |
PMID:29148537 |
RGD:151356962 |
NCBI chr10:13,533,570...13,552,290
|
|
|
G |
Acvr1b |
activin A receptor type 1B |
ameliorates |
ISO |
|
RGD |
PMID:30061637 |
RGD:151665492 |
NCBI chr 7:134,164,987...134,208,389
|
|
G |
Ada |
adenosine deaminase |
treatment |
ISO |
|
RGD |
PMID:17952507 |
RGD:152995277 |
NCBI chr 3:152,398,745...152,422,854
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26139392 |
|
NCBI chr10:34,920,992...35,126,465
|
|
G |
Ago1 |
argonaute RISC component 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 5:138,722,111...138,757,118
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 7:106,907,209...106,994,124
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20682992 |
|
NCBI chr 8:78,986,252...79,022,638
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 8:55,423,945...55,425,729
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:24928783 PMID:25231345 PMID:26463840 PMID:26928227 PMID:29112861 PMID:24928783 More...
|
RGD:9586039 |
NCBI chr16:6,453,126...6,461,952
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Mesothelioma, malignant | ClinVar Annotator: match by term: Mesothelioma, somatic |
OMIM CTD ClinVar |
PMID:9989495 PMID:10380920 PMID:10408400 PMID:25741868 PMID:28492532 |
|
NCBI chr 2:237,501,181...237,510,821
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16850164 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
C9 |
complement C9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 2:57,300,510...57,348,759
|
|
G |
Calb2 |
calbindin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr19:38,114,435...38,141,438
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 5:56,941,402...56,948,511
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:68,820,330...68,824,906
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:67,514,095...67,515,945
|
|
G |
Ccne2 |
cyclin E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 5:29,082,169...29,094,879
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:22002241 |
RGD:11522742 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cdh5 |
cadherin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr19:815,415...854,478
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:31,592,384...31,784,732
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11453316 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19223589 PMID:21526190 PMID:29112861 PMID:37441092 |
|
NCBI chr 5:109,100,763...109,114,448
|
|
G |
Cfap45 |
cilia and flagella associated protein 45 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr13:84,989,474...85,012,880
|
|
G |
Cldn10 |
claudin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr15:95,862,785...95,954,526
|
|
G |
Cldn15 |
claudin 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr12:19,698,167...19,708,419
|
|
G |
Cldn4 |
claudin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr12:27,388,160...27,389,958
|
|
G |
Cldn5 |
claudin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr11:82,212,822...82,214,248
|
|
G |
Cldn8 |
claudin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr11:27,875,857...27,878,106
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 1:94,800,456...94,809,002
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 8:80,547,592...80,665,665
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26463840 |
|
NCBI chr 4:120,366,540...120,392,502
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 2:198,065,400...198,084,774
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr 8:129,517,576...129,544,661
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 4:152,060,781...152,073,628
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr14:13,608,894...13,613,965
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr14:16,007,166...16,012,077
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr X:9,479,532...9,493,169
|
|
G |
Ddx51 |
DEAD-box helicase 51 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr12:46,011,303...46,015,989
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27032653 |
|
NCBI chr14:106,811,769...106,890,961
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27032653 |
|
NCBI chr14:95,378,626...95,551,358
|
|
G |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26807072 |
|
NCBI chr X:128,270,941...128,593,074
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16697254 |
|
NCBI chr13:95,246,079...95,275,852
|
|
G |
F9 |
coagulation factor IX |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr X:143,388,642...143,433,143
|
|
G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 7:28,597,609...28,712,908
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:17,706,011...17,737,702
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr15:32,208,993...32,254,952
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 9:80,645,507...80,714,200
|
|
G |
Fth1 |
ferritin heavy chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26818092 |
|
NCBI chr 1:216,052,037...216,054,325
|
|
G |
Gpr27 |
G protein-coupled receptor 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:132,328,364...132,329,497
|
|
G |
Gpr37 |
G protein-coupled receptor 37 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:54,138,860...54,160,927
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
DNA:deletion:cds (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16697254 PMID:7606714 |
RGD:7495814 |
NCBI chr 2:198,338,005...198,346,007
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 9:99,950,972...100,200,994
|
|
G |
Heph |
hephaestin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26818092 |
|
NCBI chr X:65,160,628...65,412,457
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 4:19,628,902...19,700,467
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
disease_progression |
ISO |
protein:increased expression:mesothelium (human) |
RGD |
PMID:18681782 |
RGD:152975625 |
NCBI chr 1:185,497,815...185,547,380
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr10:91,308,608...91,319,536
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23621518 |
|
NCBI chr 4:79,391,367...79,525,923
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:29,390,300...29,405,194
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr17:66,849,974...66,898,665
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:38,906,460...38,908,810
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Ilk |
integrin-linked kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23045294 |
|
NCBI chr 1:169,500,716...169,506,972
|
|
G |
Kat5 |
lysine acetyltransferase 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26780987 |
|
NCBI chr 1:212,325,089...212,332,640
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr14:32,901,615...32,978,895
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr14:41,466,433...41,779,477
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr20:3,622,291...3,625,852
|
|
G |
Mcam |
melanoma cell adhesion molecule |
disease_progression |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22784439 PMID:23621518 PMID:23621518 |
RGD:7364782 |
NCBI chr 8:44,479,391...44,487,575
|
|
G |
Mdk |
midkine |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 3:77,901,134...77,903,997
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:46,756,823...46,864,041
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr20:12,790,919...12,791,784
|
|
G |
Mir125a |
microRNA 125a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 1:58,677,626...58,677,710
|
|
G |
Mir126a |
microRNA 126a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21483773 |
|
NCBI chr 3:29,813,150...29,813,267
|
|
G |
Mir32 |
microRNA 32 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27716620 |
|
NCBI chr 5:71,596,083...71,596,152
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:887,684...887,760
|
|
G |
Mlana |
melan-A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr 1:227,469,537...227,483,343
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19190155 PMID:27032653 |
|
NCBI chr10:14,771,946...14,781,382
|
|
G |
Mtmr4 |
myotubularin related protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:72,890,665...72,913,598
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr 2:176,933,312...176,938,497
|
|
G |
Nanos1 |
nanos C2HC-type zinc finger 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 1:259,897,663...259,901,561
|
|
G |
Nat2 |
N-acetyltransferase 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16697254 PMID:15993904 |
RGD:5131858 |
NCBI chr16:26,974,874...27,005,191
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23435014 PMID:26463840 PMID:26678224 PMID:26928227 PMID:29112861 PMID:37441092 PMID:32271879 PMID:16166281 More...
|
RGD:150530636, RGD:150530640 |
NCBI chr14:79,627,399...79,710,709
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25162674 |
|
NCBI chr 2:192,589,580...192,642,971
|
|
G |
Osmr |
oncostatin M receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 2:57,634,517...57,688,802
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21543585 |
|
NCBI chr13:94,839,484...94,871,295
|
|
G |
Pdpn |
podoplanin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr 5:155,601,691...155,635,656
|
|
G |
Pllp |
plasmolipin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr19:10,315,104...10,335,892
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 5:131,741,959...131,824,000
|
|
G |
Pycard |
PYD and CARD domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26935421 |
|
NCBI chr 1:192,032,124...192,033,419
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:150,352,158...150,412,813
|
|
G |
Rxra |
retinoid X receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 3:31,387,892...31,474,415
|
|
G |
Ryr2 |
ryanodine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr17:58,389,925...58,975,641
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr20:12,372,345...12,381,159
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27032653 |
|
NCBI chr 6:31,562,799...31,585,267
|
|
G |
Sema4f |
semaphorin 4F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 4:115,411,411...115,437,721
|
|
G |
Serpina4 |
serpin family A member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 6:122,999,970...123,009,083
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple (human) |
CTD RGD |
PMID:26928227 PMID:27834213 |
RGD:150429641 |
NCBI chr 8:119,390,207...119,475,863
|
|
G |
Setdb1 |
SET domain bifurcated histone lysine methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr 2:182,898,738...182,930,283
|
|
G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr 9:56,492,403...56,532,300
|
|
G |
Shbg |
sex hormone binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28377727 |
|
NCBI chr10:54,332,939...54,350,409
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:38,008,303...38,035,474
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr 5:138,002,522...138,030,742
|
|
G |
Smarca2 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 1:233,617,277...233,784,908
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20617513 |
|
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Tbl1xr1 |
TBL1X/Y related 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 2:104,788,950...104,929,055
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26818092 |
|
NCBI chr 8:103,789,780...103,816,487
|
|
G |
Tfdp2 |
transcription factor Dp-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr 8:96,760,459...96,901,466
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr13:98,160,075...98,261,771
|
|
G |
Tnfrsf8 |
TNF receptor superfamily member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23056237 |
|
NCBI chr 5:157,123,183...157,168,421
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 PMID:37441092 |
|
NCBI chr10:54,798,871...54,810,300
|
|
G |
Traf7 |
TNF receptor associated factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr10:13,533,570...13,552,290
|
|
G |
Txn1 |
thioredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27032653 |
|
NCBI chr 5:77,507,455...77,519,685
|
|
G |
Ulk2 |
unc-51 like autophagy activating kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26928227 |
|
NCBI chr10:46,951,038...47,029,844
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22784439 |
|
NCBI chr17:81,577,261...81,585,746
|
|
G |
Wnt3 |
Wnt family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:89,180,224...89,224,195
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Mesothelioma, malignant CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:1302008 PMID:1327525 PMID:1338906 PMID:1655284 PMID:1658787 PMID:6307071 PMID:7795587 PMID:8295405 PMID:9090524 PMID:9398852 PMID:9499425 PMID:9529364 PMID:9536098 PMID:9607189 PMID:9745866 PMID:10470095 PMID:10505700 PMID:10762296 PMID:11182928 PMID:12970737 PMID:15150775 PMID:15509792 PMID:16439601 PMID:17496156 PMID:17541636 PMID:17576681 PMID:17694336 PMID:17853480 PMID:20442690 PMID:21499692 PMID:21508141 PMID:22099579 PMID:22784439 PMID:23295293 PMID:23497137 PMID:23515051 PMID:23715653 PMID:23935527 PMID:24033266 PMID:24856380 PMID:25349199 PMID:25501161 PMID:25623218 PMID:25741868 PMID:25818337 PMID:26069768 PMID:26248470 PMID:26467025 PMID:27013732 PMID:27719739 PMID:27899157 PMID:28204945 PMID:28492532 PMID:28780565 PMID:29474669 PMID:30406062 PMID:30963316 PMID:32352694 PMID:32581362 PMID:32604935 PMID:32891756 PMID:34490048 PMID:35904974 More...
|
|
NCBI chr 3:112,019,721...112,068,454
|
|
G |
Wwc1 |
WW and C2 domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25756049 |
|
NCBI chr10:20,300,735...20,454,393
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
treatment |
ISO |
|
RGD |
PMID:22982660 |
RGD:151347428 |
NCBI chr 1:89,268,721...89,296,619
|
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:27422796 |
RGD:127229946 |
NCBI chr16:6,453,126...6,461,952
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
exacerbates |
ISO |
mRNA:increased expression:pleura, lung (human) |
RGD |
PMID:17253596 |
RGD:153344528 |
NCBI chr10:103,567,369...103,580,069
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
ameliorates |
ISO |
mRNA:increased expression:pleura, lung (human) |
RGD |
PMID:17253596 |
RGD:153344528 |
NCBI chr 3:188,425,392...188,430,174
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
ameliorates |
ISO |
|
RGD |
PMID:18722110 |
RGD:151667912 |
NCBI chr 1:126,123,425...126,249,181
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
mRNA:increased expression:peritoneum�� (human) |
RGD |
PMID:24722292 |
RGD:150524278 |
NCBI chr18:56,834,152...56,860,804
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
exacerbates |
ISO |
mRNA:decreased expression:mesothelium of pleural cavity (human) |
RGD |
PMID:25023662 |
RGD:153323312 |
NCBI chr 1:258,626,584...258,633,594
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
mRNA, protein:increased expression:pleura |
RGD |
PMID:22028491 |
RGD:126781718 |
NCBI chr 4:76,624,399...76,687,362
|
|
G |
Il7r |
interleukin 7 receptor |
disease_progression |
ISO |
|
RGD |
PMID:26155428 |
RGD:151347688 |
NCBI chr 2:58,452,393...58,477,757
|
|
G |
Kdm6a |
lysine demethylase 6A |
|
ISO |
mRNA:increased expression:mesothelium of pleural cavity (human) |
RGD |
PMID:28197626 |
RGD:150429737 |
NCBI chr X:6,920,374...7,060,027
|
|
G |
Mir192 |
microRNA 192 |
|
ISO |
miRNA:decreased expression:pleura (human) |
RGD |
PMID:26125439 |
RGD:11529530 |
NCBI chr 1:212,994,209...212,994,318
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
miRNA:decreased expression:pleura (human) |
RGD |
PMID:26125439 |
RGD:11529530 |
NCBI chr10:64,672,343...64,672,454
|
|
G |
Mir200b |
microRNA 200b |
|
ISO |
miRNA:decreased expression:pleura (human) |
RGD |
PMID:26125439 |
RGD:11529530 |
NCBI chr 5:171,931,495...171,931,589
|
|
G |
Mlh1 |
mutL homolog 1 |
disease_progression |
ISO |
|
RGD |
PMID:23810210 |
RGD:126848799 |
NCBI chr 8:120,074,871...120,112,109
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
ameliorates |
ISO |
protein:increased expression:mesothelium of pleural cavity (human) |
RGD |
PMID:22011668 |
RGD:153002578 |
NCBI chr 5:5,835,642...6,069,693
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
disease_progression |
ISO |
DNA:loss of heterozygosity |
RGD |
PMID:27378628 PMID:26928227 PMID:26493618 |
RGD:150530638, RGD:150429647, RGD:11553131 |
NCBI chr14:79,627,399...79,710,709
|
|
G |
Rad21 |
RAD21 cohesin complex component |
|
ISO |
|
RGD |
PMID:19380173 |
RGD:150520037 |
NCBI chr 7:85,177,715...85,204,657
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
disease_progression |
ISO |
DNA:mutations:CDS:multiple (human) |
RGD |
PMID:26928227 PMID:33691361 |
RGD:150429647, RGD:150520202 |
NCBI chr 8:119,390,207...119,475,863
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
protein:increased expression:pleura |
RGD |
PMID:22199264 PMID:24912849 |
RGD:151361201, RGD:151660330 |
NCBI chr19:66,843,808...66,872,412
|
|
G |
Smo |
smoothened, frizzled class receptor |
disease_progression |
ISO |
DNA:missense mutations |
RGD |
PMID:23379358 PMID:33209614 |
RGD:150521620, RGD:150521621 |
NCBI chr 4:59,311,084...59,341,280
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
ameliorates |
ISO |
mRNA:increased expression:pleura, lung (human) |
RGD |
PMID:17253596 |
RGD:153344528 |
NCBI chr X:125,756,107...125,803,979
|
|
|
G |
Lats1 |
large tumor suppressor kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma |
ClinVar |
|
|
NCBI chr 1:3,980,801...4,014,029
|
|
G |
Lats2 |
large tumor suppressor kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma |
ClinVar |
|
|
NCBI chr15:35,940,632...35,992,225
|
|
G |
Mecom |
MDS1 and EVI1 complex locus |
|
ISO |
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma |
ClinVar |
|
|
NCBI chr 2:114,837,815...115,393,052
|
|
G |
Traf7 |
TNF receptor associated factor 7 |
|
ISO |
DNA:missense mutations:multiple |
RGD |
PMID:30171198 |
RGD:151356964 |
NCBI chr10:13,533,570...13,552,290
|
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
IAGP |
DNA:deletion |
RGD |
PMID:20065947 |
RGD:7248760 |
NCBI chr 5:109,100,763...109,114,448
|
|